BECTON DICKINSON & CO (BDX) earnings date, results and what the price requires
NYSE · SEC CIK 0000010795 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $4.98B | $377.0M | $1.37 | Filing |
| Mar 31, 2026 | May 7, 2026 | $4.71B | $-311.0M | $-1.11 | Filing |
| Dec 31, 2025 | Feb 9, 2026 | $5.25B | $382.0M | $1.34 | Filing |
| Sep 30, 2025 | Oct 15, 2025 | $7.47B | $493.0M | $1.71 | Filing |
| Jun 30, 2025 | Aug 7, 2025 | $4.73B | $574.0M | $2.00 | Filing |
| Mar 31, 2025 | May 1, 2025 | $4.48B | $308.0M | $1.07 | Filing |
| Dec 31, 2024 | Feb 5, 2025 | $5.17B | $303.0M | $1.04 | Filing |
| Sep 30, 2024 | Nov 7, 2024 | $5.44B | $400.0M | $1.37 | Filing |
What would BECTON DICKINSON & CO have to report for its valuation to change?
At $193.76, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 38.0% a year, to $16.56. On that path the next quarter needs diluted EPS near $2.36, against $1.71 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 38.0% | 38.0% |
| EPS needed in final year | $16.56 | $16.56 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. BDX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.